Helixmith Co. Ltd Asset Resilience Ratio
Helixmith Co. Ltd asset resilience ratio. Helixmith Co. Ltd (084990) has an Asset Resilience Ratio of 32.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Helixmith Co. Ltd (084990) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Helixmith Co. Ltd (2010–2025)
Asset resilience ratio of Helixmith Co. Ltd from 2010 to 2025. This chart shows how Helixmith Co. Ltd's Asset Resilience Ratio has changed over time. Read 084990 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Helixmith Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 084990 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩45.26 Billion | 32.37% |
| Total Liquid Assets | ₩45.26 Billion | 32.37% |
Asset Resilience Insights
- Very High Liquidity: Helixmith Co. Ltd maintains exceptional liquid asset reserves at 32.37% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Helixmith Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Helixmith Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FarmStory Co. Ltd
KQ:027710 |
Food & Tobacco | 2.55% |
|
Inti Kapuas Arowana Tbk
JK:IIKP |
Food & Tobacco | 0.11% |
|
Fantasy Network Ltd
TA:FNTS |
Food & Tobacco | 0.84% |
|
MSC Co. Ltd
KQ:009780 |
Food & Tobacco | 14.30% |
|
KC Feed Co. Ltd
KQ:025880 |
Food & Tobacco | 14.86% |
Helixmith Co. Ltd Asset Resilience Ratio by Year (2010–2025)
Helixmith Co. Ltd asset resilience ratio by year from 2010 to 2025. The table below shows the annual Asset Resilience Ratio data for Helixmith Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 34.83% | ₩49.88 Billion ≈ $33.80 Million |
₩143.20 Billion ≈ $97.04 Million |
-16.29pp |
| 2024-12-31 | 51.12% | ₩76.11 Billion ≈ $51.58 Million |
₩148.89 Billion ≈ $100.90 Million |
+0.97pp |
| 2023-12-31 | 50.15% | ₩113.98 Billion ≈ $77.24 Million |
₩227.28 Billion ≈ $154.02 Million |
+26.07pp |
| 2022-12-31 | 24.08% | ₩61.18 Billion ≈ $41.46 Million |
₩254.06 Billion ≈ $172.17 Million |
+1.43pp |
| 2021-12-31 | 22.65% | ₩63.99 Billion ≈ $43.37 Million |
₩282.50 Billion ≈ $191.45 Million |
-12.72pp |
| 2020-12-31 | 35.37% | ₩169.13 Billion ≈ $114.62 Million |
₩478.14 Billion ≈ $324.03 Million |
-18.42pp |
| 2019-12-31 | 53.79% | ₩199.81 Billion ≈ $135.41 Million |
₩371.44 Billion ≈ $251.72 Million |
+22.18pp |
| 2018-12-31 | 31.61% | ₩89.85 Billion ≈ $60.89 Million |
₩284.24 Billion ≈ $192.62 Million |
-14.27pp |
| 2017-12-31 | 45.88% | ₩82.30 Billion ≈ $55.77 Million |
₩179.38 Billion ≈ $121.57 Million |
-31.17pp |
| 2016-12-31 | 77.05% | ₩137.18 Billion ≈ $92.96 Million |
₩178.04 Billion ≈ $120.65 Million |
+69.15pp |
| 2013-12-31 | 7.90% | ₩5.50 Billion ≈ $3.73 Million |
₩69.62 Billion ≈ $47.18 Million |
-2.40pp |
| 2012-12-31 | 10.30% | ₩7.01 Billion ≈ $4.75 Million |
₩67.99 Billion ≈ $46.08 Million |
-3.66pp |
| 2011-12-31 | 13.97% | ₩8.40 Billion ≈ $5.69 Million |
₩60.14 Billion ≈ $40.75 Million |
+13.95pp |
| 2010-12-31 | 0.01% | ₩9.57 Million ≈ $6.49K |
₩69.60 Billion ≈ $47.17 Million |
-- |
About Helixmith Co. Ltd
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more